Proton translocation coupled to trimethylamine N-oxide reduction in anaerobically grown Escherichia coli.
Proton translocation coupled to trimethylamine N-oxide reduction was studied in Escherichia coli grown anaerobically in the presence of trimethylamine N-oxide. Rapid acidification of the medium was observed when trimethylamine N-oxide was added to anaerobic cell suspensions of E. coli K-10. Acidification was sensitive to the proton conductor 3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile (SF6847). No pH change was shown in a strain deficient in trimethylamine N-oxide reductase activity. The apparent H+/trimethylamine N-oxide ratio in cells oxidizing endogenous substrates was 3 to 4 g-ions of H+ translocated per mol of trimethylamine N-oxide added. The addition of trimethylamine N-oxide and formate to ethylenediaminetetraacetic acid-treated cell suspension caused fluorescence quenching of 3,3'-dipropylthiacarbocyanine [diS-C3-(5)], indicating the generation of membrane potential. These results indicate that the reduction of trimethylamine N-oxide in E. coli is catalyzed by an anaerobic electron transfer system, resulting in formation of a proton motive force. Trimethylamine N-oxide reductase activity and proton extrusion were also examined in chlorate-resistant mutants. Reduction of trimethylamine N-oxide occurred in chlC, chlG, and chlE mutants, whereas chlA, chlB, and chlD mutants, which are deficient in the molybdenum cofactor, could not reduce it. Protons were extruded in chlC and chlG mutants, but not in chlA, chlB, and chlD mutants. Trimethylamine N-oxide reductase activity in a chlD mutant was restored to the wild-type level by the addition of 100 microM molybdate to the growth medium, indicating that the same molybdenum cofactor as used by nitrate reductase is required for the trimethylamine N-oxide reductase system.
D000693:Anaerobiosis; D002704:Chlorates / Q000494:pharmacology; D003067:Coenzymes; D004926:Escherichia coli / Q000378:metabolism*; D006859:Hydrogen / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials; D008667:Metalloproteins; D008744:Methylamines / Q000378:metabolism*; D008982:Molybdenum / Q000494:pharmacology / Q000502:physiology; D000090006:Molybdenum Cofactors; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D009565:Nitrate Reductases / Q000378:metabolism; D010084:Oxidation-Reduction; D000587:Oxidoreductases Acting on CH-NH Group Donors; D011621:Pteridines / Q000502:physiology
D002704:Chlorates; D003067:Coenzymes; D006859:Hydrogen; D008667:Metalloproteins; D008744:Methylamines; D008982:Molybdenum; D000090006:Molybdenum Cofactors; D009247:NADH, NADPH Oxidoreductases; D009565:Nitrate Reductases; D000587:Oxidoreductases Acting on CH-NH Group Donors; D011621:Pteridines; C022261:molybdopterin; C021567:methylamine dehydrogenase; C005855:trimethyloxamine